Pires, Intranasal Drug Delivery - How Why What for -Extensive Review, J Pharm Pharmaceut Sci 2009
Pharm Drug File
-
Upload
unknownxem -
Category
Documents
-
view
215 -
download
0
Transcript of Pharm Drug File
-
7/25/2019 Pharm Drug File
1/46
Drug Use against Cidal/static
Sulfonamides Uncomplicated UTIs, nocardia, chlamydia Static
Trimethoprim TMP- bacterial, pyrimethamine- protozoa (toxo, malaria
!luoro"uinolones (Cipro, le#o$loxacin Cidal
Methenamine Urinary tract disin$ectant
Phenazopyridine Urinary tract analgesic (not antimicrobial
-lactams Cidal
Penicillin %/& %ram ' cocci, treponema, actinomyces
taph aureus Cidal
)ide spectrum -ampicillin, amoxicillin %ram ' and -
*nti-pseudomonal- piperacillin Pseudomonas, gram - +.
Cephalosporins
%en - ce$azolin
%en 0- ce$oxitin %ram '/- (12s P2c3 4 h $lu, 2nterobacter, neiss5, serratia
%en 6-ce$triaxone, ce$azimide %ram 4 only (eisseria, pseudomonas
%en 7- ce$epime )ide spectrum, gram '/-
Carbapenems (imi/mero %ram '/-, aerobic, anaerobic
Monobactam 4 aztreonam %ram - aerobes
&ancomycin %ram ' only Cidal
Macrolides Static
2rythromycin %ram ' cocci and atypical pneumonias
Clarithromycin ame as erythro ' 15 $lu*zithromycin C trachomatis (not $or gram ' cocci
Clindamycin Static
treptogramins &82 $aecium
inezolid
Chloramphenicol tatic
Tetracycline tatic
*minoglycosides *erobic, intracellular (pseudomon, tularemia, etc Cidal
Isoniazid TB only Cidal
C! in$x, osteomyelits, prostatitis, 2 coli, pseudomonas,almonella, Cipro $or pulm anthrax prophylaxis
*cid stable penicillin 4 na$cillin,methicillin, ox
6rdgen may be used $or empiric tx
%ram ', same as Pen % (plus P2c3 4 proteus, e coli,9elbsiell
Strep, anaerobes above the diaphram, topical for
acne!rosacea, t" for to"o # pyrimetham, bone inf"
Together cidal, alone-static
%ram ' anaerobes, &82 ($aecium and $aecalis, M8*,M8 2pidermitidis
1$lu, intracell (ric9ettsia, psittacosis, typhoid, anaerobic,meningitis
:ntracell- chlamydia, legionella, mycoplasma pneumo, lyme,ric9ettsial, rosacea, acne
3anamycin (easily inacti#ated, *mi9acin(not easily inacti#ated
-
7/25/2019 Pharm Drug File
2/46
$ifampin Cidal
%yranizamide Cidal
&thambutol TB only Static
TB polytherapy, t" for leprosy, prophyla"is for 'eisseriamenin, ( flu
-
7/25/2019 Pharm Drug File
3/46
*bsolute/relati#e
)bsolute
8elati#e
8elati#e (higher a$$inity $or bacteria
8elati#e
)bsolute
*bsolute
*bsolute
$elative
Metabolized by C.P7;n into ammonium and $ormaldehyde in acidic p1 (;5;
Urine turns red
Irreversibly inhibits transpeptidase, may stimulate autolysins
*moxicillin ' cla#ulanic acid ? augmentin
ame as penicillin
Mero- tx meningitis
1igh resistance to @-lactamases
=inds D-alaD-ala, inhibits T%ase $rom elongating chain
Binds % site of .S ribosome subunit, t-$') dissociates, inhibits translocation
=est $or intracellular in$ections
Binds .S subunit of ribosome, inhibits peptidyl transferase +active metabolite underoes entero-hepatic recirculation
* (dal$opristin inhibits donor/accept site on peptidyltrans$erase, changes shape5 = ("uinpristin inhibits translocation
=inds ;
-
7/25/2019 Pharm Drug File
6/46
Bloc*s 1') dep $') pol- no initiation for m$') synth
%rodru is activated by TB to pyrazinoic acid
Inhib arabinosyl transferase 2 arabinoalactan is not polymerized in cell 3all
-
7/25/2019 Pharm Drug File
7/46
3inetics
4ral, penetrates CS5 3ithout inflam, crosses placenta, binds albumin, acetylated and lucuronic con6
+ral, +. le#o enters C, mainly renal elim,
Time dependent *illin +above MIC 7.8 in 9: hrs, not metabolized, renal elim, enter C'S 3hen inflamed
% (intra#enousB & (oral
Methicillin- :&
+ral
:&
ame as penicillin
:& only, enters C!
:M or :&, enters C!
lo> :& admin (oral $or C5 di$, C in$lam only, not metabolized, urine
4ral, intracell, do not enter C'S, elim mainly biliary +less renal
!ormulated >ith ester or enteric coated to protect $rom stomach acid
(ih oral absorption, reaches bone, does not enter C'S, intracell, "placenta, mainly hepatic metabolism and biliary e"cretion
Continuous :& (short hal$-li$e, intracellular (PM and macros, non-enzymatic metabolism to non-acti#e metabolites
+ral,
-
7/25/2019 Pharm Drug File
8/46
4ral +very lipophilic, C'S!bone, enterohep circ, de-acetylated form is elim via biliary
4ral, 3ell distributed
4ral, concentrates in $BCs, .8 metabolized, elim via *idneys
-
7/25/2019 Pharm Drug File
9/46
Toxicity/*d#erse 8eactions
Crystalluria, *ernicterus +not for babies, preos, 6aundice in adults, hemolytic anemia in 0;%11
Megaloblastic anemia in people >ith poor diets/lo> $olic acid- pregnant or homeless
ong FT, tendinitis, transient arthropathy, photosensiti#e
=ladder irritation in high doses,
'euroto"ic +seizures-0)B), cation to"icity
Methicillin- nephritis
*mpicillin- macropapular rash (not allergy
:mipenem is con#ulsant at high doses
ephrotoxic and +totoxicB thrombophlebitis at site o$ admin
Motility, arrhythmia, cholestasis, rash, eosinophilia
2pigastric distress, Eaundice, trans ototoxicity
2pigastric distress, Eaundice, trans ototoxicity
'
-
7/25/2019 Pharm Drug File
10/46
(epatoto"ic, hydro"y pyrazinoic acid metabolite interferes 3ith uric acid e"cretion
4ptic neuritis, decreased visual acuity and color vision +dose dep, uric acid accumulates in blood +3orse 3 out
)symptomatic elevated liver enzymes, hepatitis 3 6aundice in liver disease pts, red body fluids, hih dose therapyno loner used
-
7/25/2019 Pharm Drug File
11/46
*llergy
S=S 2 necrotizin dermatitis
)naphyla"is +cross-reaction 3ith other ? lactams
!ast in$usion -K 8ed Man yndrome
$ash and fever are rare
+T !+8 hepatic insu$$iciency pts (increased ammonia, not $or renalinsu$$iciency pts (crystalluria
-
7/25/2019 Pharm Drug File
12/46
Mild rash
-
7/25/2019 Pharm Drug File
13/46
:nteractions
*ntacids/dairy di/tri#alent ions chelate and decrease absorption, inter$eres >ith C.P7;< metabolism (>ar$arin, theophylline
+T ):T1 sul$a drugs- $ormaldehyde $orms precipitate
Clavulanic acid +not antimicrobial inhibits ?-lactamase@ %robenecid increases half-life
:nhibits *D1 causing disul$iram-li9e e$$ect (ce$amandole/ce$operazone
:nhibits C.P-7;< metabolism o$ >ar$arin, theophylline, digoxin
:nhibits C.P-7;< metabolism o$ >ar$arin, theophylline, digoxinD+2 +T :1:=:T C.P-7;/ *mphotericin = in candidemiaand cryptococcal meningitis
$eFuires acidic environment to dissolve, does not enter CS5 3ell, hihmetabolism
-
7/25/2019 Pharm Drug File
22/46
Toxicity/*d#erse 8eactions *llergy
&D, enterocolitis, ele#ated hepatic enzymes, bone marro> suppression
/&T4- less se" steroid synth, less cortisol synth, severe hepatoto"icity
5lu- very tolerable
1eadache, &D, rare hepatotoxic 8ash
1eadache, C, %:, augments alcohol e$$ect
%i distress, $lushing $rom histamine release
nephrotoxicity is dose-limiting but cant be dialyzedB in$usion reactions(chills, $e#er, muscle spasms, hypotension arrhythmias, anemia,thrombophlebitis
'
-
7/25/2019 Pharm Drug File
23/46
:nteractions 8esistance
%henytoin decreases GitraconazoleH
mica$ungin increases le#els o$ ni$edipine and cyclosporine
Inhib C% dru metabolizersA increased levels of otherdrus
Cross sensiti#ity >ith penicillins5 +T !+8 acute intermittentporphyria
-
7/25/2019 Pharm Drug File
24/46
Drug Use against
Metronidazole
Chloro"uine (7- amino"uinolone
Prima"uine
*rtemisinin Malaria
odium stibogluconate eshmania
Pentamidine Pneumocystis Eiro#ecii pneumonia, sleeping sic9ness
=enzimidazoles helminths
Mebendazole *scaris, >hip >orm, hoo9 >orms, pin>orm, spiralis
*lbendazole Cysticercosis, hydatid cysts
:#ermectin trongyloides, +nchocerca
Prazi"uantel Cestode, $lu9es
1ru 4bserved &ffects on (elminths
*lbendazole
Mebendazole
Pyrantel pamoate
Diethylcarbamazine
:#ermectin
Prazi"uantel
2ntamoeba, giardia, bacteroides, trichomonas #ag,clostridium, anaerobic in$x
Malaria, extra-intestinal amebiasis, high doses areanti in$lammatory $or 8*/2
Malaria in tissue schizonts and hypnozoites (not $orintra-8=C
:nhibition o$ glucose transportB depletion o$ glycogenstores, inhibition o$ $umarate reductase
:nhibition o$ glucose transportB depletion o$ glycogenstores
Muscles depolarize, increased spi9e >a#e acti#ity,spastic paralysis
1yperpolarization and paralysis o$ >ormsmusculatureB exposure o$ antigens, leading toantibody binding and attac9 by phagocytes
*lters chloride currents, resulting in death o$micro$ilariae
Depolarization o$ muscles, increased intracellularCa '' , displacement o$ schistosomes to the humanli#er, exposure o$ sur$ace antigens, binding byantibody and phagocytes, tegument disruption
-
7/25/2019 Pharm Drug File
25/46
iclosamide
1ru %ossible Mechanism of )ction
Metronidazole
Paromomycin :nhibits protein synthesis
itazoxanide
Chloro"uine
Fuinine
Me$lo"uine
Pyrimethamine :nhibits dihydro$olate reductase
ul$onamides
i$urtimox
2$lornithine
Melarsoprol 8eacts >ith sul$hydryl groups, inhibits proteins
Uncouples phosphorylationB may inhibit anaerobicmetabolism
*cti#ated >hen reduced by $erredoxins, reacts >ithD* and other parasite constituents
:nhibition o$ electron trans$er reactions essential tothe metabolism o$ anaerobic organisms
Concentrated in hemoglobin-containing digesti#e#esicles, inhibits heme polymerase
Concentrated in $ood #acuoles, probably inhibitsheme polymerase
Concentrated in $ood #acuoles, may $orm toxiccomplexes >ith heme
:nhibit binding o$p -aminobenzoic acid todihydropteroate synthetase
!orms reacti#e +0species that damage cell
membranes and D*
:rre#ersibly inhibits ornithine decarboxylase, inhibitspolyamine synthesis
-
7/25/2019 Pharm Drug File
26/46
Cidal/static *bsolute/relati#e
Cidal
Cidal 8elati#e 4 higher a$$inity $or helminths
Coadmin >ith steroids to reduce in$lammation
%ossible Mechanism of )ction
=inding to @-tubulin
Depolarizing neuromuscular bloc9ade
1yperpolarization and neuromuscular bloc9ade
*ltered chloride channel $unction
Uncertain
8elati#e- bacterial metabolites (+1-!8, ?+, +1xare more reacti#e than human metabolite (10
=inding to @-tubulin, pre#ents microtubulepolymerization
-
7/25/2019 Pharm Drug File
27/46
Uncertain
-
7/25/2019 Pharm Drug File
28/46
Mechanism 3inetics
Un9no>n (maybe 2TC +ral, complete metabolize to urine
:&, #ery slo> elim
Un9no>n :& or #ia inhalation $or pneumonia, not metabolized
Coadmin o$ steroids to lo>er in$lammation +ral, acti#e metabolite, renal elim
+ral, no C, enters eye, elim unchanged in $eces
itro group on metro accepts electrons $rom ameba2TCL $orms toxic products L damages D*
+ral, enters C!, in breast mil9, al9yl chain isoxidized and glucuronidated, ;n products to hemozoin
+ral, high &d, "uic9ly binds proteins, high le#els inli#er, spleen, 9idney5 ot metabolized long hal$-li$e
:nter$eres >ith glycosome in the organism so itcannot generate *TP/%TP
=inds tubulin and bloc9s MT $ormation, bloc9glucose upta9eL no *TP
+ral tablet must be che>ed, rapid metabolism andexcretion
*cti#ates glutamate gated Cl channels, paralysis o$pharyngeal muscles
2nhances Ca in$lux, >orm contracts mucles,paralysis
+ral, D+ +T C12), binds albumin, gooddistribution to C!, mil9, bile, poo, metabolized
-
7/25/2019 Pharm Drug File
29/46
-
7/25/2019 Pharm Drug File
30/46
Toxicity/*d#erse 8eactions *llergy
1emolytic anemia in %PDD
:n$lam (Mazotti rxn due to death o$ micro$ilariae
!e#er, sedation, itching, rash, edema
&D, headache, dry mouth, metallic taste, disul$irame$$ect, ithium toxicityQ
%:, long term use associated >ith diplopia, T >a#e,arrhythmia, death (in 8* pts, can cause #isualchanges, =ulls eye lesion
+nly gi#en in patient, muscle and Eoint pain, T >a#echanges, shoc9, death
=loc9s symp ner#es and causes hypotension,histamine release, toxic to islet cells (hypoglycemiaand then diabetes, damages 9idneys
Dead org causes headache, #omit, mental statuschange, hyperthermia5 ong term therapy- li#erdamage, leu9openia
-
7/25/2019 Pharm Drug File
31/46
-
7/25/2019 Pharm Drug File
32/46
:nteractions 8esistance
1igh resistance #ia e$$lux pump
Dead orgs in brain release proin$lam mediators
Potentiates oral anticoags, phenytoin increases elimo$ metro, cimetidine increases RmetroS,
Do not gi#e >ith anti-seizure drugs (benzo,barbiturate or #alproic acid
-
7/25/2019 Pharm Drug File
33/46
-
7/25/2019 Pharm Drug File
34/46
Metal Acute
Arsenic Nausea, vomiting,
"rice-water" diarrhea,
encephalopathy,
MODS, LoQS,
pain!ul neuropathy
ismuth #enal !ailure$ acute tu%ular necrosis
&admium 'neumonitis (o)ide !umes*
&hromium
&o%alt eer drin+ers (dilated* cardiomyopathy
&opper lue vomitus, . irritation/ hemorrhage, hemolysis, MODS (ingested*$ M00 (inhaled*
. hemorrhage, hemolysis, acute renal !ailure (&r12ingestion*
-
7/25/2019 Pharm Drug File
35/46
.ron 3omiting, . hemorrhage, cardiac depression, meta%olic acidosis
Lead Nausea, vomiting, encephalopathy (headache, sei4ures, ata)ia, o%tundation*
Manganese M00 (inhaled*
Mercury 5lemental (inhaled*6 !ever, vomiting, diarrhea, AL.$
.norganic salts (ingestion*6 caustic gastroenteritis
-
7/25/2019 Pharm Drug File
36/46
Selenium &austic %urns, pneumonitis, hypotension
Silver 3ery high doses6 hemorrhage, %one marrow suppression, pulmonary edema, hepatorenal necrosis
hallium 5arly6 3omiting, diarrhea, pain!ul neuropathy, coma, autonomic insta%ility, MODS
M00 (o)ide !umes*$ vomiting, diarrhea, a%dominal pain (ingestion*Zinc[6]
-
7/25/2019 Pharm Drug File
37/46
Chronic
Dia%etes,
hypopigmentation/ hyper+eratosis,
cancer6 lung, %ladder, s+in, encephalopathy
Di!!use myoclonic encephalopathy
'roteinuria, lung cancer, osteomalacia
'ulmonary !i%rosis, lung cancer (inhalation*
'neumoconiosis (inhaled*$ goiter
vineyard sprayers lung (inhaled*$ 7ilson disease (hepatic and %asal ganglia degeneration*
-
7/25/2019 Pharm Drug File
38/46
8epatic cirrhosis
5ncephalopathy, anemia, a%dominal pain, nephropathy, !oot-drop/ wrist-drop
'ar+inson-li+e syndrome,
Occupational (inhaled*6 pulmonary !i%rosis, reduced sperm count, nasopharyngeal tumors
respiratory, neuropsychiatric[5]
Nausea, metallic taste, gingivo-stomatitis, tremor, neurasthenia, nephrotic syndrome$ hypersensitivity('in+ disease*
-
7/25/2019 Pharm Drug File
39/46
rittle hair and nails, red s+in, paresthesia, hemiplegia
Argyria6 %lue-grey discoloration o! s+in, nails, mucosae
Late !indings6 Alopecia, Mees lines, residual neurologic symptoms
&opper de!iciency6 anemia, neurologic degeneration, osteoporosis
-
7/25/2019 Pharm Drug File
40/46
Toxic Concentration
9:-h urine6
;g/L urine, or
?== >g/g creatinine
No clear re!erence standard
'roteinuria and/or ;?< >g/ g creatinine
No clear re!erence standard
Normal e)cretion6
=@?-?@9 >g/L (serum*
=@?-9@9 >g/L (urine*
Normal e)cretion6
9< >g/9: h (urine*
-
7/25/2019 Pharm Drug File
41/46
Nonto)ic6 B== >g/dL
Severe6 Cg/dL
No clear re!erence standard
ac+ground e)posure "normal" limits6
?= >g/L (whole %lood*$ 9= >g/L (9:-h urine*
5)cessive e)posure6
Pediatric: symptoms or [Pb] 45 /dL b!ood"# $du!t: symptoms or [Pb] %& /dL[4]
-
7/25/2019 Pharm Drug File
42/46
; >g/L (%lood*
Severe poisoning6
;g/L (-h urine*
Mild to)icity6 ESeF C?mg/L (serum*$ Serious6 C9 mg/L
Asymptomatic wor+ers have mean EAgF o! ?? >g/L (serum* and 9@1 >g/L (spot urine*
o)ic6 CB >g/L (%lood*
Normal range6
=@1-?@? mg/L (plasma*
?=-?: mg/L (red cells*
-
7/25/2019 Pharm Drug File
43/46
Treatment
AL (acute, symptomatic*
Succimer
DM'S (5urope*
G
G
NA& (e)perimental*
NA&
AL
D-'enicillamine
&aNa95DA
-
7/25/2019 Pharm Drug File
44/46
De!ero)amine
AL
Succimer
G
AL
Succimer
DM'S (5urope*
&aNa95DA
-
7/25/2019 Pharm Drug File
45/46
G
Selenium, vitamin 5 (e)perimental*
MDA&
'russian %lue
G
-
7/25/2019 Pharm Drug File
46/46
First-Line Drugs for Tuberculosis
Inhibitors of protein synthesis (Rifamycins)
Inhibitors of cell wall synthesis (Isoniazid others)
!thers
"econd-Line Drugs for Tuberculosis
Fluoro#uinolones
$minoglycosides
!thers
Drugs for Leprosy
Dapsone
Fluoro#uinolones
Rifamycins
Tetracyclines
Drugs for %ycobacterium $&ium
%acrolides